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ABREVIATIONS 
 
Dox : doxycycline 
DTT : dithiothreitol 
IPTG : isopropyl-β-D-thiogalactopyranoside 
PAGE : polyacrylamide gel electrophoresis 
PBS : phosphate-buffered saline 
PMSF : Phenylmethanesulfonylfluoride 
RNase : ribonuclease 
TA : toxin-antitoxin 
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ABSTRACT 
Toxin-antitoxin (TA) loci are widely distributed in chromosomes and plasmids 
of Bacteria and Archaea. Chromosomes of some of these bacteria contain several TA 
loci, especially in one of the Mycobacterium species, M. tuberculosis, which possesses 
the largest number of putative TA loci on its chromosome, accounting for 79 loci. TA 
systems consist of two small genes that encode a low molecular weight toxic protein 
(toxin) which reacts with intracellular target molecules related to essential cellular 
processes, such as DNA replication, protein translation, membrane integrity, and cell 
wall synthesis, and a cognate antitoxin protein or RNA that inhibits toxin activity. 
Initially, TA loci were reported to play a role in bacterial programmed cell death for 
maintaining plasmid stability by killing the daughter cells that failed to inherit the 
plasmids, or for acting as antiviral factors. More recently, it was recognized that the 
toxins play roles in response to cellular stresses, such as amino acid starvation and the 
presence of antibiotics, and triggering bacterial persistence. Currently, TA systems are 
grouped into six classes according to the mechanisms used by the antitoxins to 
neutralize the activities of the toxins. Type II toxin-antitoxin (TA) loci are characterized 
by encoding two proteins, a stable toxin and an unstable antitoxin which neutralizes the 
toxin activity by forming a protein complex. In stress conditions, the unstable antitoxin 
protein is promptly degraded via proteolysis so that the toxin is released from protein 
complex and becomes active to react with intracellular target molecules, such as mRNA 
at the ribosomal A site, initiator tRNA
fMet
, Sarcin-Ricin loop of 23S rRNA or 
glutamyl-tRNA synthetase and EF-Tu proteins, to inhibit cell growth or finally lead to 
cell death. TA systems are not redundant, as each system may have developed to 
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respond to specific stresses. Understanding of the detailed chemical and physiological 
functions of toxins is important for interpretation of their roles in bacterial physiology.  
Despite many studies on mesophilic bacteria, including pathogens, the 
mechanisms and roles of TA systems in thermophilic microorganisms remain unknown. 
Based on the toxin-antitoxin database, 12 TA loci are predicted to be present in the 
Thermus thermophilus HB27 genome, of which seven are classified into known type II 
TA families, three (TTC1395-TTC1394, TTC1549-TTC1548, and TTC1705-TTC1704) 
in HicAB family and four (TTC0113-TTC0114, TTC0125-TTC0126, 
TTC1207-TTC1208, and TTC1804-TTC1805) in VapBC family. However, 
experimental analyses on these TA loci have not yet been reported. Here, I analyzed 
genetically these seven loci, and detailed biochemical analyses of TTC0125-TTC0126 
were conducted.  
Similarity searches of seven putative toxins in T. thermophilus genome with the 
validated toxins in the Uniprot database indicated low-to-moderate similarities. 
TTC0113, TTC0125, TTC1207, and TTC1804 showed 24, 44, 12, and 13 % similarity 
to VapC of Mycobacterium smegmatis (VAPC_MYCS2), and TTC1395, TTC1549 and 
TTC1705 showed 37, 13 and 42 % similarity to HicA of Escherichia coli, respectively. 
Expression of these putative toxin genes in E. coli showed that one VapC toxin 
TTC0125 and two HicA toxins TTC1395 and TTC1705 inhibited cell growth, especially 
at 43 °C, and co-expression with their cognate antiotoxin genes rescued the growth, 
indicating that these genes actually function as TA.  
VapC family proteins contain a PIN domain and function as RNases. In order 
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to assess the molecular function of VapC in T. thermophilus, I purified protein of VapC 
toxin TTC0125 and its cognate VapB antitoxin TTC0126 for biochemical analysis, and 
RNase assays were conducted using total RNA isolated from both E. coli and T. 
thermophilus, and an in vitro-transcribed mRNA as substrates. The results showed that 
TTC0125 has an RNase activity to rRNA and mRNA, and this activity was inhibited by 
addition of the antitoxin TTC0126. Moreover, TTC0125 does not possess substrate- or 
sequence-specificity, rather it degrades free RNA. Translation inhibition assays showed 
that TTC0125 inhibited protein synthesis by degrading mRNA but not by inactivation of 
ribosome via degradation of rRNA in intact ribosomes. Second, I conducted 
site-directed mutagenesis to identify catalytically-important residues of TTC0125. The 
result of growth inhibition assay and in vitro RNase assay, using purified mutant 
proteins, showed that 9 residues, D4, E40, A76, G94, G98, D99, S102, D119, and D124, 
are important for the toxin activity of TTC0125. A three-dimensional model of 
TTC0125, constructed by the Phyre2 program, indicated that most of the residues, 
except for G94 and D124, are putative catalytic residues or located around the putative 
catalytic center, suggesting that these residues are involved in catalysis, substrate 
binding or structural maintenance of the catalytic center. 
 
Keywords: Thermus thermophilus; toxin-antitoxin; VapBC; HicBA; glyoxylate-malate 
metabolism   
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CHAPTER I - INTRODUCTION 
Section I - Thermophiles and Evolution of Life 
1-1-1 Ancestral life 
Theoretical studies for the origin of life and its early evolution are the key to 
understanding about life. The first chemical traces of life had been found in the rocks 
from Precambrian deep-sea vents, at times between 3.5 and 3.9 Gyr ago (Stetter, 2006). 
Microfossils whose structures showed remarkable resemblance to bacteria and 
cyanobacteria, found in Apex cherts of the Warrawoona Group in Western Australia 
from ~3,465-million-year-old, currently provide the oldest morphological evidence for 
life on Earth (Brasier et al., 2002). These had been the times at the end of the heavy 
meteorite bombardment. The surface of the early Earth must have been much hotter 
than today (Stetter, 2006). Only superheat-loving microbes similar to the 
hyperthermophiles would have been able to thrive and survive in such an ‘early times of 
life’ scenario (Stetter, 2006).  
Those of hyperthermophilic archaea and bacteria are found at the deepest and 
shortest branches in the phylogenetic trees, located near “origin of life”, and therefore it 
has been proposed that the common ancestors of Archaea and Bacteria were 
hyperthermophilic (Akanuma et al., 2013; Pace, 1991; Stetter, 2006; Woese, 1987). 
Not only theoretical studies, but the experimental support for the existence of a 
thermophilic universal common ancestor was supplied (Akanuma et al., 2013). 
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Akanuma et al present the thermal stabilities and catalytic efficiencies of nucleoside 
diphosphate kinases (NDK), designed using the information contained in predictive 
phylogenetic trees, that seem to represent the last common ancestors of Archaea and of 
Bacteria. These enzymes display extreme thermal stabilities, therefore it has been 
proposed that the common ancestors of Archaea and Bacteria were hyperthermophilic 
(Akanuma et al., 2013). 
1-1-2 Thermophiles 
Thermophiles and hyperthermophiles are present in various regions of the 
Earth, including volcanic environments, hot springs, mud pots, fumaroles, geysers, 
coastal thermal springs, and even deep-sea hydrothermal vents (Urbieta et al., 2015). 
The first thermophiles which exhibited unprecedented optimal growth temperatures 
above 80°C were isolated thirty-five years ago (Stetter, 2006). Hot springs are one of 
the main sites where hyperthermophiles and thermophiles are isolated, although they 
can also thrive in man-made environments, such as the compost facilities (Rastogi et al., 
2010; Urbieta et al., 2015). From then thermophiles had turned out to be very common 
in geothermal environmet and deepsea. Currently, only two bacterial families are 
categorized as hyperthermophiles (Aquificaceae and Thermotogaceae), while the 
majority of hyperthermophiles are Archaea (Urbieta et al., 2015). 
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Figure 1-1-1 Universal phylogenetic tree determined from rRNA sequence 
comparisons (Woese et al, 1987).   
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Section II - Thermus thermophilus 
1-2-1 The phylum Deinococcus-Thermus 
Deinococcus-Thermus is a phylum of bacteria, which are highly resistant to 
environmental hazards. This phylum is a distinct branch of bacteria (Griffiths and Gupta 
2007), which includes two genus of extremophilic bacteria: the thermophilic order 
thermales named Thermus and the highly radioresistant order Deinococcus. The genus 
Deinococcus includes at least eleven, mostly mesophilic species known for their 
extreme resistance to γ-irradiation and other agents causing DNA damage (Omelchenko 
et al. 2005), and the genus Thermus currently consists of 14 species. 
1-2-2 Thermus thermophilus 
Thermus spp. are belong to Deinococcus-Thermus group. They are aerobic, 
rod-shaped, nonsporulating, gram-negative bacteria, and most of Thermus species grew 
at an optiomum temperature of between 70°C and 75 °C, with pH ranges between 7.5 
and 8.0  (Koyama, Hoshino, Tomizuka, & Furukawa, 1986). Thermus species use 
several substrates for growth, including carbohydrates, amino acids, carboxylic acids, 
and peptides (R. Huber et al. 2004), and no strain of Thermus appears to be capable of 
fermentation (R. Huber et al. 2004 ).The natural genetic competence of many Thermus 
strains makes it possible to carry out genetic studies of these organisms, and also to 
construct expression systems of heterologous thermophilic genes (Takayama, Kosuge, 
Maseda, Nakamura, & Hoshino, 2004). 
The gram-negative bacterium Thermus thermophilus, was isolated from hot spring 
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in Japan (Henne et al. 2004; Oshima and Imahori 1974), which can grow up to 85 ºC. 
This organism has been known as an extremely thermophilic model organism, as many 
thermostable proteins isolated from members of the genus Thermus are indispensable in 
research and in industrial applications (Henne et al., 2004). T. thermophilus also has 
aroused interest for structural biological researchers. For example, 
“Structural-Biological Whole Cell Project” which I participated in Japan aims to 
understand all biological phenomena in the cell of one strain of T. thermophilus. Now 
several kinds of proteins have been crystallized and used for X-ray crystallographic 
analyses. As biomolecule structure informational advances and the coming determinate 
collaboration with groups of bioinformatics, T. thermophilus is expected to be an 
important model organism for atomic biology and chemical biology, which will be a 
new research field in the future (Wimberly et al., 2000). 
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Section III - Toxin-Antitoxin System 
1-3-1 Toxin-antitoxin system  
Toxin-antitoxin (TA) loci are widely distributed in chromosomes and plasmids 
of Bacteria (Makarova et al. 2009) and in Archaea as well (Grønlund and Gerdes 1999). 
The chromosomes of some of these bacteria contain several TA loci, especially in one of 
the Mycobacterium species, M. tuberculosis, which possesses the largest number of 
putative TA loci on its chromosome, accounting for 79 loci (Ramage et al. 2009).  
TA systems consist of two small genes that encode a low molecular weight 
toxic protein (toxin) which reacts with intracellular target molecules related to essential 
cellular processes, such as DNA replication, protein translation, membrane integrity, and 
cell wall synthesis (Bertram and Schuster 2014; Maisonneuve et al. 2013; Page and Peti 
2016), and a cognate antitoxin protein or RNA that inhibits toxin activity.  
Initially, TA loci were reported to play a role in bacterial programmed cell 
death for maintaining plasmid stability by killing the daughter cells that failed to inherit 
the plasmids (Winther and Gerdes 2011). More recently, it was recognized that the 
toxins play roles in response to cellular stresses (Bertram and Schuster 2014), such as 
amino acid starvation and the presence of antibiotics (Fauvart et al. 2011; Gerdes et al. 
2005; Maisonneuve and Gerdes 2014). The vast majority of TA systems in 
chromosomes of Bacteria and Archaea are not redundant, likely due to each system 
developing different responses to specific stresses (Wang and Wood 2011).  
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1-3-2 Types of toxin-antitoxin system 
The genetic organization of the known TA loci is in general organized into 
operons in which the first cistron encodes the antitoxin and the second cistron encodes 
the toxin. But a little exceptions to this rule are existed, one known example is the hig 
locus of Rts1, in which the upstream cistron codes for the toxin (Gerdes, 2000).  
As part of antitoxins showed weak similar sequences (Ruiz-Echevarría, de 
Torrontegui, Giménez-Gallego, & Díaz-Orejas, 1991), and also part of non-cognate 
toxin-antitoxins can functionally interact (Zhu, Sharp, Kobayashi, Woychik, & Inouye, 
2010), It is suggested that TA loci maybe arose from a common ancestral gene (Gerdes, 
2000). 
Currently, TA systems are grouped into six classes according to the 
mechanisms used by the antitoxins to neutralize the activities of the toxins. Toxin 
products of all six types are proteins, while antitoxins of them are different molecules.  
Well-established TA systems has three types: type I TA system consists of a 
protein toxin and a small regulatory antisense RNA antitoxin, which makes base-pairs to 
the toxin mRNA to inhibit its translation; type II TA system consists of a stable toxin 
protein and an unstable antitoxin protein, which forms a protein complex with the toxin 
protein and inhibits the toxin activity as well as represses the transcription of TA loci; 
antitoxin in type III system is also a small RNA, however, different with in type I, it 
forms pseudoknots that bind directly to the toxin protein to block its toxic activity, 
instead of binds to the mRNA of toxin (Page & Peti, 2016). The most recently identified 
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TA systems are types IV–VI: antitoxin of type IV is also a protein and directly protects 
the target intracellular molecule of toxin, but never interacts with toxin protein; in the 
only known type V system, the antitoxin is an RNase, cleaving specifically the toxin 
mRNA under growth conditions; type VI is composed of a protein toxin and a protein 
antitoxin too, in which the antitoxin is a proteolytic adaptor protein that neutralizes 
toxin’s toxicity by promoting its degradation by other protease (Page & Peti, 2016). 
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CHAPTER II – IDENTIFICATION OF PUTATIVE TOXIN-ANTITOXIN 
SYSTEMS IN THERMUS THERMOPHILUS HB27 
Section I - Introduction 
The type II TA system is composed of a stable toxin protein and an unstable 
antitoxin protein. Under normal growth conditions, the antitoxin neutralizes toxin 
activity by forming a stable protein complex. When an environmental stressor is present, 
the antitoxin protein is degraded via proteolysis such that the toxin is released from the 
protein complex and becomes active to target intracellular molecules, such as mRNA at 
the ribosomal A site (Christensen and Gerdes 2003), initiator tRNA
fMet
 (Winther and 
Gerdes 2011), Sarcin-Ricin loop of 23S rRNA (Winther et al. 2013), and 
glutamyl-tRNA synthetase (Germain et al. 2013), to inhibit cell growth or cause cell 
death. Most type II toxins function as RNases for degrading mRNA, either in a 
ribosome-dependent or independent manner (Unterholzner et al. 2014), such as MazF, 
Kid, ChpBK, MqsR, VapC, and HicA. 
VapBC of type II TA system is the most widely expanded TA family and its 
toxin VapC contains a PIN domain, which generally functions as a nuclease enzyme that 
cleaves single stranded RNA (Arcus et al. 2011).  
HicAB is a novel Type II TA system family identified by Makarova et al. 
(2006), but little is known about its function. Escherichia coli HicA toxin inhibits the 
cell growth by mRNA degradation (Jørgensen et al. 2009), and HicA from Burkholderia 
pseudomallei and Pseudomonas aeruginosa induces growth arrest and persistence in the 
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presence of ciprofloxacin or ceftazidime (Butt et al. 2014; Li et al. 2016). 
Despite many investigations in mesophilic bacteria, especially in pathogens, 
have been reported, the mechanisms and roles of TA systems in thermophilic bacteria 
are still undefined. In the toxin-antitoxin database (Shao et al. 2011), 12 TA loci are 
predicted in the genome of T. thermophilus HB27, of which seven are classified into 
known TA families, three (TTC1395-TTC1394, TTC1549-TTC1548, and 
TTC1705-TTC1704) in HicAB family and four (TTC0113-TTC0114, 
TTC0125-TTC0126, TTC1207-TTC1208, and TTC1804-TTC1805) in VapBC family. 
However, no experimental analyses on these TA loci have been provided so far. Here I 
report the results of genetic analyses of these seven loci. 
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Section II - Materials and Methods 
2-2-1 Bacterial strains, plasmids and media 
 T. thermophilus HB27 was used for genome isolation. E. coli strain DH5αZ1 
(DH5α harboring attB:: PlacI
q
-lacI, PN25-tetR, Sp
r
; Lutz and Bujard 1997) was used for 
plasmid construction and expression of toxin/TA genes from pZE21MCS2 (ColE1ori, 
PLtetO-1, Kn
r
; Lutz and Bujard 1997). DH5αZ1 and pZE21MCS2 were purchased from 
Expressys. T. thermophilus and E. coli strains were cultured in TM medium (Table 
2-2-1) (Koyama et al. 1986) at 70 °C and in LB medium at 37 °C, respectively.  
2-2-2 Plasmid construction 
To construct plasmids expressing the toxin genes or the TA modules under the 
control of a strictly regulated promoter, PLtetO-1, each toxin gene or the TA locus was 
PCR-amplified with the primers listed in Table 2-2-2 from the T. thermophilus HB27 
genome. Then, fragments were digested with KpnI and SalI, which were added just 
upstream of the initiation codon and downstream of the termination codon, respectively, 
and cloned into the respective sites of pZE21MCS, using strain DH5αZ1 as a host. All 
plasmid constructs were confirmed by nucleotide sequencing with a CEQ8000XL DNA 
sequencer (Beckman-Coulter). 
2-2-3 Alignment and phylogenetic analysis  
Phylogenetic tree based on amino acid sequences of the 7 toxins in strain T. 
thermophilus HB27 and typeical VapC and HicA was calculated. Seven toxins in T. 
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thermophilus HB27, and several amino acid sequences showing similarities to these 
toxins, with VapC toxin and HicA toxin amino acid sequences were selected from the 
Uniprot database (http://www.uniprot.org/uniprot). These sequences were aligned by the 
neighbor-joining method using Clustal X software and visualized by MEGA 7 software 
(The names of organisms and accession mumbers were indicated as FASTA organisms 
and accession mumbers). 
2-2-4 Growth inhibition assay 
The strain DH5αZ1 harboring the pZE21MCS2 plasmid containing each toxin 
gene or TA locus was cultured in liquid LB medium with 50 μg/mL of kanamycin at 
37ºC or 43 ºC. When the O.D.600 of the culture reached approximately 0.2, 100 ng/mL 
doxycycline (Dox) was added to induce gene expression. Cell growth was monitored 
periodically by measuring O.D.600. Three independent experiments were performed.  
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Table 2-2-1   TM medium 
 
＜TM medium＞ 
Polypepton 4 g 
Yeast Extract 2 g 
NaCl 1 g 
Castenholz solution* 100 ml 
 1 L (pH 7.5) 
＜*Castenholz solution ＞ 
Nitrirotriacetate 1 g 
CaSO4・2H2O 0.6 g 
MgSO4・7H2O 1 g 
NaCl 0.08 g 
KNO3 1.03 g 
NaNO3 6.89 g 
Na2HPO4 1.11 g 
FeCl3 solution (2.8 g/l ) 1 ml 
Nitch solution** 10 ml 
 
 1 L (pH 8.2) 
＜**Nitch solution / L＞ 
H2SO4 0.5 ml 
MnSO4・7H2O 2.2 g 
ZnSO4・7H2O 0.5 g 
CuSO4 0.016 g 
H3BO4 0.5 g 
Na2MoO4・2H2O 0.025 g 
CoCl2・6H2O 0.046 g 
 
 1 L 
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Table 2-2-2. Primers used in this chapter. 
 
Primer Sequence (5’-3’)a  
 
TTC0113F-Kpn        AAAGGTACCATGGGAAGGCGCTACCTCCTAGAC 
TTC0113R-Sal  AAAGTCGACTCACCACAGGGTCTCCACGC 
TTC0114F-Kpn  AAAGGTACCATGAAGGCCTTCACCGTGCAC 
TTC0125F-Kpn  AAAGGTACCATGGTGCTGGACGCTTCCGC 
TTC0125R-Sal  AAAGTCGACTCAGGAGGGCTTCCACGCCA 
TTC0126F-Kpn  AAAGGTACCATGGCCCTCACCATCCGCAAC 
TTC1207F-Kpn  AAAGGTACCATGAGGGTCGTCCTGGACACC 
TTC1207R-Sal  AAAGTCGACTCAGCTCACCTCCCGCAAAAAG 
TTC1208F-Kpn  AAAGGTACCATGCGGCGCATTGCCCTGC 
TTC1395F-Kpn  AAAGGTACCGTGAGCCCCCGCCTCATCC 
TTC1395R-Sal  AAAGTCGACTCAACGGGATCCAAGGCGCTTTTG 
TTC1394F-Kpn  AAAGGTACCAGATGAGGCGGCGTTACCG 
TTC1549F-Kpn  AAAGGTACCATGGCCAAGGGGGGGCAC 
TTC1549R-Sal  AAAGTCGAC CTAGAGGTTATGGAACTC 
TTC1548F-Kpn  AAAGGTACCATGCTCAAGTACACCGCCCTCC 
TTC1705F-Kpn  AAAGGTACCATGGCGAGGCGGCTTAGGC 
TTC1705R-Sal  AAAGTCGACTCACTCCAGCCATTCCTCCTCCTC 
TTC1704F-Kpn  AAAGGTACCATGGACGGGATGGGCACCCTG 
TTC1805F-Kpn  AAAGGTACCATGATGCATCGCAAGCGCGTC 
TTC1805R-Sal  AAAGTCGACCTAGCGTCCAGCACCACCCAG 
TTC1804F-Kpn  AAAGGTACCATGAGCTGGGTGGTGCTGGACGC 
 
a
 The restriction sites introduced are underlined, and the initiation and termination 
codons are shown in bold. 
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Section III - Result 
2-3-1 Analysis of TA locus in T. thermophilus  
In the genome of T. thermophilus HB27, seven TA loci were predicted as 
known TA families in the toxin-antitoxin database (Shao et al. 2011). Similarity 
searches of these putative toxins with the validated ones in the Uniprot database indicate 
low to moderate similarities (Table 2-3-1): TTC0113, TTC0125, TTC1207 and 
TTC1804, classified in the VapC family, showed 24, 44, 12 and 13% similarity to the 
VapC of Mycobacterium smegmatis (VAPC_MYCS2) (McKenzie et al. 2012), and 
TTC1395, TTC1549 and TTC1705 showed 37, 13 and 42% similarity to HicA of E. coli 
(HICA_ECOLI) (Jørgensen et al. 2009). Likewise, their cognate anititoxins also showed 
similar results: TTC0114, TTC0126, TTC1208 and TTC1805 showed 24, 37, 18 and 
47% similarity to the VapB antitoxin of M. smegmatis (VAPB_MYCS2), and TTC1394, 
TTC1548 and TTC1704 showed 27, 35 and 27% similarity to the HicB antitoxin of E. 
coli (HICB_ECOLI).  
2-3-2 Phylogenetic analysis 
The phylogenetic tree based on the amino acid sequences of the seven toxins 
from T. thermophilus and those from the database showed that four predicted VapC 
toxins are clustered with known VapC toxins, and three predicted HicA toxins are 
clustered with known HicA toxins (Fig. 2-3-1), confirming the results by similar 
research (Tabel 2-3-1) and also in accordance with the predicted results by Shao et al 
(2011). 
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2-3-2 Identification of TA systems using toxin-mediated growth inhibition 
assays 
To test whether these seven TA loci are functional, the toxin genes were cloned 
with or without their cognate antitoxin genes into the plasmid pZE21MCS2, and 
expressed under the control of PLtetO-1 promoter in E. coli. This promoter is strictly 
regulated in the presence of TetR repressor in strain DH5αZ1, and the expression can be 
induced by addition of Dox (Lutz & Bujard, 1997). E. coli DH5αZ1 harboring the 
plasmids were cultured in LB medium containing kanamycin at 43ºC, and cell growth 
was monitored by measuring O.D.600. At O.D.600 ≈ 0.2, Dox was added to induce gene 
expression.  
As shown in Fig. 2-3-2 (a), expression of one VapC (TTC0125) and two HicA 
(TTC1395, TTC1549) genes strictly inhibited the cell growth, whereas that of other 
toxin genes had almost no effect. The growth-inhibitory effects of the former three toxin 
genes were more obvious at 43 °C than that at 37 °C (Figure 2-3-3). Moreover, the 
effects of growth inhibition by expression of toxin genes were completely cancelled by 
co-expression with their cognate antitoxin genes (Fig. 2-3-2 b).  
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Table 2-3-1 Toxin-antitoxin genes in T. thermophilus HB27 
  Toxin Antitoxin 
VapBC 
VapC VapB 
TTC0113 (26%)* TTC0114 
TTC0125 (41%)* TTC0126 
TTC1207 (19%)* TTC1208 
TTC1804 (37%)* TTC1805 
*Similarity with VAPC8_MYCBO from Mycobacterium bovis  
TA family  Toxin Antitoxin 
HicBA 
HicA HicB 
TTC1395*(26%) TTC1394  
TTC1549*(25%) TTC1548  
TTC1705* (23%) TTC1704 
*Similarity with HICA_ECOLI from E. coli 
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Figure 2-3-1 Phylogenetic relationships of toxin genes from Bacteria and Archaea.  
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Figure 2-3-2 Growth inhibition assay.  
E. coli DH5αZ1 harboring pZE21MCS2 containing toxin genes (a) of TTC0113 (1), 
TTC0125 (2), TTC1207 (3), TTC1804 (4), TTC1395 (5), TTC1549 (6), TTC1705 (7), 
or those with respective antitoxin genes (b) were cultured in LB medium containing 
kanamycin at 43 ºC; cell growth was monitored by measuring O.D.600. At O.D.600≈0.2, 
Dox was added to induce gene expression. Open circles with dotted lines indicate the 
culture without induction and filled circles with solid lines indicate the culture with 
induction. Panel (8) indicates the results from the strain harboring the vector plasmid. 
Culturing was conducted three times, and the mean values ±standard deviations are 
shown. 
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Figure 2-3-3 Growth inhibition test triggered by induction of TTC0125 (a) or 
TTC0125-TTC0126 (b) at 37 ºC.  
E. coli DH5αZ1 harboring pZE21MCS2 containing toxin genes (a) of TTC0125 or 
TTC0125-TTC0126 (b) were cultured in LB medium containing kanamycin at 37 ºC; 
cell growth was monitored by measuring O.D.600. At O.D.600≈0.2, Dox was added to 
induce gene expression. Blue lines indicate the culture without induction and orange 
lines indicate the culture with induction. 
 
  
22 
 
Section IV - Discussion 
In the genome of T. thermophilus HB27, 12 TA loci were predicted in the 
toxin-antitoxin database, but only seven loci were predicted as known TA families (Shao 
et al. 2011). To confirm these data, I did BLAST to know the similarity of the 4 
predicted VapC toxin (TTC0113, TTC0125, TTC1207, and TTC1804) and 3 predicted 
HicA toxins (TTC1395, TTC1549 and TTC1705) with the validated toxins in the 
Uniprot database, and indicated that they have low-to-moderate similarities as shown in 
Table 2-3-1. Futhermore, I performed a phylogenetic tree based on amino acid 
sequences of the 7 toxins with typical VapC and HicA toxins, and showed that four 
predicted VapC toxins are clustered with known VapC toxins, and three predicted HicA 
toxins are clustered with known HicA toxins (Fig. 2-3-1), confirming that TTC0113, 
TTC0125, TTC1207, and TTC1804 are VapCs, and TTC1395, TTC1549, TTC1705 are 
HicAs. 
However, there were no experimental data describing whether they are 
functional TA loci or not. To test whether these seven TA loci are functional, the toxin 
genes were cloned with or without their cognate antitoxin genes into the plasmid 
pZE21MCS2 and expressed under the control of the PLtetO-1 promoter in E. coli. As 
shown in Fig. 2-3-2 (a), expression of one VapC (TTC0125) and two HicA (TTC1395, 
TTC1549) genes strictly inhibited cell growth, and the growth-inhibitory effects of the 
former three toxin genes were more evident at 43 °C than at 37 °C (Fig. 2-3-3), 
indicating that these toxins are more active at higher temperatures. Moreover, the effects 
were canceled out by co-expression of their cognate antitoxin genes (Fig. 2-3-2 b).So, I 
concluded that at least these three loci function as type II TA systems in T. thermophilus. 
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Additionally, as shown in Fig. 2-3-2 (a), expression of other 4 TA loci (TC0113, 
TTC1207, TTC1804 and TTC1549) did not affect their cell growth parttern, indicating 
that they are not functional, at least to 43 °C. The method used is restricted by assay 
temperature, as an E. coli strain is used as the host. Therefore, I cannot exclude the 
possibility that these four toxins may also possess toxin activities at higher temperatures, 
i.e. the growth temperature of T. thermophilus. One similar example is Mycobacterium 
tuberculosis, which harming 48 VapBC TA loci in its genome. Growth inhibition assay 
of the 48 VapBC TA loci in its genome were tested using M. smegmatis as a host, and 
showed that not all of toxins triggered significant cell growth inhibition (K. Winther, 
Tree, Tollervey, & Gerdes, 2016). So, I supposed that maybe the unfunctional toxins 
normally exist in all the genomes of microorganisms though we have not known the 
reason for their existence.   
 In this chapter, I discussed all the VapBC and HicBA TA loci in T. 
thermophilus by genetic analysis, and identified that three Type II TA loci, includes one 
VapBC and two HicBA, are functional TA loci, as toxin expression inhibited cell growth 
effectively and expression of its cognate antitoxin neutralized their effects. 
 In the next chapter, I will focus on the TTC0125-TTC0126 locus, the only 
functional VapBC TA locus in T. thermophilus, for further analysis. 
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CHAPTER III – IDENTIFICATION OF ENZYME ACTIVITY 
OF TTC0125-TTC0126 LOCUS 
Section I – Introduction 
Genetic analyses in the former chapter showed that TTC0125-TTC0126 locus 
is a VapBC of type II TA system, the most widely expanded TA family in Bacteria and 
Archaea. The VapC toxin is identified by containing a PIN domain, which generally 
functions as a nuclease enzyme that cleaves single stranded RNA (Arcus et al. 2011). 
Proteins of PIN-domain family are included in eukaryotes, eubacteria and archaea, and 
often be found in most of prokaryotic organisms including many famous pathogens. For 
example, M. tuberculosis, one of the most devastating pathogenic bacteria, contains 45 
VapBC loci (Arcus et al. 2011), but most of them are not well characterized until now. 
PIN domain is identified by three highly conserved negatively-charged amino acids, and 
is predicted to have an RNase activity (Arcus et al. 2011). VapC toxins from different 
organisms were reported to have different target specificities. For example, VapC20 of 
M. tuberculosis inhibits translation by cleavage of 23S ribosomal RNA (Winther et al. 
2013), and both VapC of Shigella flexneri and VapCLT2 of Salmonella enterica 
site-specifically cleave initiator tRNA (Winther and Gerdes 2011). On the other hand, 
VapC-mt4 of M. tuberculosis degrades mRNA (Sharp et al. 2012). 
The mechanisms and roles of VapBC in thermophilic bacteria are still 
undefined. I will describe biochemical analyses to identify the enzyme activity of 
TTC0125-TTC0126 locus and their target intracellular molecules in this chapter.  
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Section II - Materials and methods 
3-2-1 Bacterial strains, plasmids and media 
 T. thermophilus HB27 was used for genome isolation and purification of total 
RNA. E. coli strain DH5αZ1 was used for plasmid construction of 
pET28-TTC0125-TTC0126 and pET28-TTC0126. E. coli strain Rosetta (DE3) was 
used for production of TTC0125/TTC0126 proteins with plasmid pET28a. T. 
thermophilus and E. coli strains were cultured in TM medium (Koyama et al. 1986) 
with shaking at 70 °C and LB medium at 37 °C, respectively.  
3-2-2 Plasmid construction 
 For production and purification of TTC0125 toxin and TTC0126 anititoxin, the 
TA locus and TTC0126 alone were PCR-amplified with primers TTC0126 F NdeI and 
TTC0125 R XhoI, and TTC0126 F NdeI and TTC0126 R XhoI (Table 3-2-1), 
respectively. The resultant fragments were cloned into the respective sites of pET28a, 
giving rise to pET28-TTC0125-TTC0126 and pET28-TTC0126, respectively. In both 
plasmids, TTC0126 was fused in-frame with the 6xHis-tag in the vector at the 
N-terminus, and the XhoI site was located just downstream of the termination codon of 
TTC0125 of pET28-TTC0125-TTC0126 and TTC0126 of pET28-TTC0126. 
The TT_P0042 gene encoding a β-glycosidase was PCR-amplified and cloned 
into pET28a, giving rise to pET28-TTP0042. This plasmid was used for in vitro 
transcription and translation assays. The tetR gene from E. coli was also cloned into 
pET28 to construct pET28-tetR, and used for in vitro transcription and RNase assays.  
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All the plasmid constructs were confirmed by nucleotide sequencing with a 
CEQ8000XL DNA sequencer (Beckman-Coulter). 
3-2-3 Purification of TTC0125 and TTC0126 
TTC0125 toxin was purified essentially according to Winther and Gerdes 
(2011). E. coli Rosetta (DE3) harboring pET28-TTC0125-TTC0126 was cultured in LB 
medium supplemented with 50 μg/ml kanamycin and 20 μg/ml chloramphenicol at 
30 °C. When O.D.600 reached to 0.5, 0.2 mM IPTG was added, and after further 
culturing for 5 h, cells were collected by centrifugation at 5,000 x g for 10 min at 4 °C. 
Then the cells were re-suspended in ice-cold Lysis buffer (50 mM NaH2PO4, 100 mM 
NaCl, 20 mM imidazole, 0.5 mM PMSF (SIGMA), pH7.4), and disrupted by sonication. 
After the cell debris was removed by centrifugation at 10,000 x g for 20 min at 4 ºC, a 
Ni-NTA agarose resin (Qiagen) was added to the supernatant and incubated for 2 h at 4 
ºC, and subsequently loaded onto a gravity column. The column was washed 
extensively with Wash buffer (50 mM NaH2PO4, 100 mM NaCl, 20 mM imidazole, pH 
7.4), and the protein complex of TTC0125-TTC0126 was eluted with Elution buffer (50 
mM NaH2PO4, 100 mM NaCl, 200 mM imidazole, pH 7.4). Next, the protein complex 
was denatured by dialyzing the complex overnight at 4 ºC with Denaturation buffer (100 
mM NaH2PO4, 10 mM Tris–HCl, 9.8 M Urea, pH 7.4), and the solution was again 
loaded onto a Ni-NTA agarose column. The denatured TTC0125 was eluted in the 
flowthrough fraction, and refolded by subsequent four-step dialysis against: (i) 1☓PBS, 
0.1 % Triton X-100, 5 mM DTT, (ii) 1☓PBS, 5 mM DTT, (iii) 1☓PBS, 5 mM DTT, 
and (iv) 1☓ PBS, 20 % glycerol, 1 mM DTT for 4 h in each dialysis.  
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 For purification of TTC0126, E. coli Rosetta (DE3) harboring pET28- 
TTC0126 was cultured and the cell-free extract was prepared in the same way as above. 
TTC0126 was purified from the extract directly with a Ni-NTA agarose. The 
purification steps were monitored by SDS-PAGE according to Laemmli (1970).  
3-2-4 RNA degradation assay 
 One-hundred pmol of the purified TTC0125 protein, dialyzed against Reaction 
buffer (50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, pH 7.4) prior to 
the reaction, was incubated with one μg of total RNA from E. coli and T. thermophilus, 
prepared using a RNeasy Mini Kit (Qiagen), or an in vitro-transcribed tetR mRNA, 
which was prepared using pET28-tetR and an in vitro Transcription T7 Kit (TAKARA) 
and purified with RNeasy Mini Kit (Qiagen), at 50 ºC in Reaction buffer. After 5, 15, 30, 
or 60 min. incubation, the reaction was stopped by adding 1x loading buffer (47.5 % 
formamide, 0.01 % SDS, 0.01 % bromophenol blue, 0.5 mg/ml EtBr, 0.5 mM EDTA) 
and placed on ice immediately. Then the samples were loaded onto a denaturing agarose 
gel (1% agarose, 6.5% formaldehyde, 0.4 M MOPS, 100 mM sodium acetate, 10 mM 
EDTA) and analyzed. To test the inhibitory effect of TTC0126, 100 pmol of TTC0125 
was incubated with 500 pmol of the purified TTC0126, which was also dialyzed against 
Reaction buffer, at 50 ºC for 15 min. prior to the reaction, and used for the assay. 
 For activity measurement against intact ribosomes, ribosomes were purified 
from E. coli and T. thermophilus cells according to Pongs (1973) and Trauner (2011). 
Then 10 μg of TTC0125 was incubated with 50 μg of ribosomes in Reaction buffer at 
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50 ºC for 60 min., and rRNA was purified with an RNeasy Mini Kit for gel 
electrophoresis. 
 For activity measurement against tRNA, the small RNA fraction containing 
tRNA was prepared from E. coli, using ISOGEN II (NIPPON GENE). Then one μg of 
the sample was incubated with TTC0125 as described above, and resolved by an 8% 
denaturing PAGE. After the sample was electroblotted onto a Hybond-N membrane, the 
initiator tRNA was hybridized with a biotin-labelled DNA probe, tRNAMet (Table 
3-2-1). Detection was conducted with a Chemiluminescent Nucleic Acid Detection 
Module (Thermo) and a LAS-2000 detector (Fuji film). 
3-2-5 In vitro translation inhibiton assay 
An in vitro translation inhibition assay was performed under the following 
conditions, using the in vitro transcribed TT_P0042 mRNA, which was synthesized 
with pET28-TTP0042 as a template and the in vitro Transcription T7 Kit, and a 
PUREfrex 2.0 kit (GeneFrontier; Shimizu et al. 2001). For each condition, the amount 
of the purified TTC0125, TTC0126 proteins, and the template mRNA used were 45, 270 
pmol, and 2.5 µg, and the substrate-tRNA mixture (Solution I, PUREfrex), the enzyme 
mixture (Solution II), and the ribosome (Solution III) solutions used were 10, 1, and 2 
µl in a total volume of 20 µl, respectively. 
Condition 1. The template mRNA was incubated with TTC0125 at 37 ºC for 30 min. 
prior to the in vitro translation. 
Condition 2. The template mRNA was incubated with TTC0125 as above, then 
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TTC0126 was added and the solution was further incubated for 15 min. After that, the 
translation reaction was started. 
Condition 3. TTC0125 and TTC0126 were mixed and incubated at 37 ºC for 15 min., 
then the template mRNA was added and incubated further for 30 min. After that, the 
translation reaction was started. 
Condition 4. The ribosome (Solution III) was incubated with TTC0125 at 37 ºC for 30 
min., then the translation reaction was started by adding the template mRNA, Solution I 
and II. 
Condition 5. The ribosome was incubated with TTC0125 as above, then TTC0126 was 
added and the solution was further incubated for 15 min. After that, the translation 
reaction was started. 
Condition 6. TTC0125 and TTC0126 were mixed and incubated at 37 ºC for 15 min., 
then the ribosome was added and incubated further for 30 min. After that, the translation 
reaction was started. 
 The in vitro translation reaction was performed at 37 ºC for 4 h, and the 
translated TT_P0042 protein, containing the His-tag at its N-terminus, was detected by 
Western blotting, using an anti-His antibody (Qiagen) and an ECL
 
Prime Western 
Blotting Detection kit (GE Healthcare). Detection was performed using a LAS-2000 
detector (Fuji film). 
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Table 3-2-1 Primers used in this chapter. 
 
Primer Sequence (5’-3’)a  
for cloning into pET28a 
TTC0126F-Nde  AAACATATGGCCCTCACCATCCGCAAC 
TTC0126R-Xho  AAACTCGAGTCAGTACCCCTCCTTGCCGTAC 
TTC0125R-Xho  AAACTCGAGTCAGGAGGGCTTCCACGCCA 
tetRF-Nde  CCGGCATATGGCACGGCTGAACAGAGA 
tetRR-Xho  CCGGCTCGAGTCAGCAAAAGGGGATGATAAG 
TTP0042F-Nde  GAGAGCATATGACCGAGAACGCCGAAAAATTC 
TTP0042R-Xho  AATTCTCGAGTTAGGTCTGGGCCCGCGCG  
for Northern blotting 
tRNAMet probe          biotin-CCATCATTATGAGTGATGTG 
a
 The restriction sites introduced are underlined, and the initiation and termination 
codons are shown in bold. 
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Section III – Result 
3-3-1 Purification of TTC0125 and TTC0126 
For purification of TTC0125, I have adopted the method described by Winther 
and Gerdes (2011). The TTC0125-TTC0126 protein complex was first purified from the 
cell extract of E. coli Rosetta (DE3) harboring pET28-TTC0125-TTC0126 through 
affinity chromatography against the 6xHis-tag attached to the N-terminus of TTC0126, 
and the proteins were denatured by treatment with 9.8 M urea. Then the sample was 
loaded again to the Ni-NTA agarose column and TTC0125 was purified in a 
flowthrough fraction. The purified TTC0125 was renatured by a stepwise dialysis. 
TTC0126 was directly purified by the affinity chromatography from the cell extract of 
strain Rosetta (DE3) harboring pET28-TTC0126. The purified TTC0125 and TTC0126 
showed single bands on SDS-PAGE, the size of which were 14.7 and 10.0 kDa, 
respectively (Fig. 3-3-1). 
3-3-2 TTC0125 degrades free rRNA and mRNA 
VapC family proteins contain a PIN domain and function as RNases (Arcus et 
al. 2011).  
In order to assess the molecular function of TTC0125, I firstly analyzed its 
RNase activity using total RNA isolated from both E. coli (Fig. 3-3-2 a) and T. 
thermophilus (Fig. 3-3-2 b) as substrates. As shown in Fig. 3-3-2 (a) and (b), The major 
bands corresponding to 16S and 23S rRNA were gradually shifted to low 
molecular-weight fractions through the incubation time from 5 min to 60 min. (lane 1, 
32 
 
2,3,4) with TTC0125, indicating that TTC0125 degrades at least 16S and 23S rRNA 
from both the organisms. And lane 5 showed that this degradation was completely 
inhibited when TTC0125 was incubated with TTC0126 prior to the reaction, showing 
that TTC0126 functions as antitoxin.  
Then I tried the same assay using in vitro-transcribed mRNA (tetR gene coded 
by E. coli) as its substrate. As shown in Fig. 3-3-2 (c), TTC0125 degraded mRNA in the 
same manner as total RNA. 
These results indicate that TTC0125 degrades free RNAs including both rRNA 
and mRNA. 
3-3-3 TTC0125 not degrade tRNA or rRNA in intact ribosome 
For some cases, VapC toxins showed strict substrate-specificities towards 
rRNA and tRNA. So I check TTC0125’s enzyme activity toward intact ribosomes from 
E. coli and T. thermophilus, to examine whether TTC0125 has substrate specificities or 
not. After incubating intact ribosome with TTC0125 or TTC0125-TTC0126 complex, 
16S/23S rRNA was isolated from reactions using RNA purification kit. As shown in Fig. 
3-3-3 (a, b), TTC0125 did not degraded 16S/23S rRNA in intact ribosomes form both E. 
coli and T. thermophilus, even after incubation for 60 min. 
Then I assessed initiator tRNA cleavage. Small RNA fraction of E. coli isolated 
from the total RNA was used as the substrate of this assay, and the initiator rRNA was 
detected by Northern blotting (Fig. 3-3-3. c). As the same result as the rRNA in intact 
ribosme, even incubating with TTC0125 (lane 1-4) for 60 min, it showed no digestion 
for initiator tRNA.  
These results strongly indicate that TTC0125 does not possess substrate- or 
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sequence-specificity, rather it degrades free RNA. 
3-3-5 TTC0125 inhibits translation by degrading mRNA 
To obtain some insights into in vivo molecular function of TTC0125, an in 
vitro-translation inhibition assay was conducted, using a PUREFrex kit. In this assay, an 
in vitro-transcribed TT_P0042 mRNA was used as a template for translation, and the 
translated 6xHis-tagged protein was detected by Western blotting.  
The in vitro-transcribed TT_P0042 mRNA or the E. coli ribosome fraction in 
the PUREfrex 2.0 kit were incubated with the TTC0125 or TTC0125-TTC0126 
complex, as described in 3-2-5, and in vitro translation reactions were conducted by 
adding other components of the kit. The translated product was resolved by SDS-PAGE 
and detected by Western blotting with an anti-His antibody.  
A positive control without TTC0125 treatment (lane PC) produced a band of ca. 
50.8 kDa, the size of which is in good agreement of the molecular weight of TT_P0042 
with a 6x His tag. When incubating the mRNA with TTC0125 prior to translation, no 
protein production was detected (lane 1 and 2), as well as the negative control without 
the template mRNA (lane NC). On the other hand, pre-treatment of ribosome with 
TTC0125 did not affect the protein synthesis (lane 5 and 6). Also, pre-incubation of 
TTC0125 and TTC0126 did not affect translation in both cases (lane 3 and 7), showing 
that TTC0126 functions as the antitoxin of TTC0125 to inhibit its activity efficiently. 
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 Lanes 4 and 8 showed the result of a mutated TTC0125 (D99A) with mRNA 
(lane 4) or ribosome (lane 8), indicating that the D99A mutation led to complete loss of 
translation inhibition ability of TTC0125. 
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Figure 3-3-1 SDS-PAGE of the purified TTC0125 and TTC0126 proteins  
Lane M, molecular marker (in kDa); 1, TTC0125; 2, TTC0126. 
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Figure 3-3-2 RNA degradation assay.  
Total RNA from E. coli (a), T. thermophilus (b), and the in vitro-transcribed tetR mRNA 
(c) were incubated with the purified TTC0125 for 5 (lane 1), 10 (lane 2), 30 (lane 3), or 
60 (lane 4) min, or incubated with the TTC0125-TTC0126 complex (lane 5) or 
TTC0125 D99A mutant (lane 6) for 60 min and electrophoresed by denaturing agarose 
gel. Lanes C indicate the RNA samples without TTC0125 treatment, which were also 
incubated in Reaction buffer for 60 min. Positions of 23S, 16S rRNA, and mRNA are 
indicated by arrows.  
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Figure 3-3-3 RNA degradation assay with intact ribosomes from E. coli (a), T. 
thermophilus (b), and with initiator tRNA (c). 
(a, b) Intact ribosomes were incubated with TTC0125 (lane 1) or the TTC0125-TTC126 
complex (lane 2) at 50 °C for 60 min. Then, RNA was prepared and loaded onto a 
denaturing agarose gel. Lane C indicates a control experiment in which ribosomes were 
incubated in the reaction buffer for 60 min. (c) Total RNA from E. coli was incubated 
with TTC0125 for 0 (lane 1), 15 (lane 2), 30 (lane 3), or 60 min. (lane 4), or with the 
TTC0125-TTC126 complex for 0 (lane 5), 15 (lane 6), 30 (lane 7), or 60 min. (lane 8), 
and resolved by denaturing PAGE. The initiator tRNA was detected by Northern 
blotting. Lane C indicates a control experiment without incubation with TTC0125. The 
positions of 23S, 16S rRNA, and tRNAfMet are indicated by arrows.     
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Figuer 3-3-4 In vitro translation inhibition assay. 
The in vitro-transcribed TT_P0042 mRNA or the E. coli ribosome fraction in the 
PUREFrex 2.0 kit were incubated with the TTC0125 or TTC0125-TTC0126 complex, 
as described in Materials and methods, and in vitro translation reactions were conducted 
by adding other components of the kit. The translated product was resolved by 
SDS-PAGE and detected by Western blotting with an anti-His antibody. Lane 1, the 
mRNA was pre-incubated with TTC0125 (Condition 1); 2, the mRNA was 
pre-incubated with TTC0125, and then TTC0125 –TTC0126 was added (Condition 2); 
3, the mRNA was pre-incubated with TTC0125 –TTC0126 complex (Condition 3); 4, 
the mRNA was pre-incubated with TTC0125 D99A mutant in Condition 1; 5, the 
ribosome was pre-incubated with TTC0125 (Condition 4); 6, the ribosome was 
pre-incubated with TTC0125, and then TTC0126 was added (Condition 5); 7, the 
ribosome was pre-incubated with TTC0125-TTC0126 complex (Condition 6); and 8, 
the ribosome was pre-incubated with TTC0125 D99A mutant in Condition 4. Lanes NC 
and PC indicate negative control without the template mRNA addition and positive 
control without TTC0125 treatment, respectively. Lane M indicates the molecular 
marker standards (MagicMark XP Western Protein Standard, Thermo Fisher Scientific), 
the size of which are indicated on the right. The bands corresponding to the full-length 
translated product is indicated by an arrow. 
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Section IV - Discussion 
In this chapter, I described biochemical analyses to identify the enzyme activity 
of TTC0125 and its target intracellular molecules.  
Firstly, purification of TTC0125 and TTC0126 was conducted for biochemical 
analyses. Using the method described by Winther and Gerdes (2011), toxic TTC0125 
protein could be produced in E. coli as a TTC0125-TTC0126 protein complex and 
purified to homogeniety.  
Secondly, I identified the enzyme activity of TTC0125 using the purificated 
proteins of TTC0125 and TTC0126. As VapC toxin is known to possess a ribonuclease 
activity in mesophilic bacteria (Arcus et al. 2011), I performed an RNase assay using 
total RNA isolated from both E. coli and T. thermophilus as substrates (Fig. 3-3-2), and 
demonstrated that TTC0125 degrades at least 16S and 23S rRNA from both the 
organisms. TTC0126, the antitoxin of TTC0125, completely inhibited ribonuclease 
activity of TTC0125 by incubating them prior to the reaction. Some VapC toxins show 
strict substrate specificities toward rRNA and tRNA. For example, VapC20 of M. 
tuberculosis cleaves the Sarcin-Ricin loop of 23S rRNA in intact ribosome (Winther et 
al. 2013), and VapC (MvpT) of Shigella flexneri cleaves the anticodon loop of the 
initiator tRNA (Winther and Gerdes 2011). To examine whether TTC0125 has such 
substrate specificities or not, I first checked its activity toward intact ribosomes from E. 
coli and T. thermophilus (Fig. 3-3-3 a, b). The result showed that TTC0125 did not 
cleave or degrade ribosomes. For assessment of initiator tRNA cleavage, the initiator 
tRNA of E. coli was detected by Northern blot hybridization, and showed that TTC0125 
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did not react with the initiator tRNA (Fig. 3-3-3 c). On the other hand, TTC0125 
degrades in vitro-transcribed mRNA of E. coli gene (tetR) in the same manner as total 
RNA (Fig. 3-3-2 c). These results strongly indicate that TTC0125 does not have any 
substrate and sequence specificity, rather it degrades free RNA, such as VapC6 of 
Sulfolobus solfataricus (Maezato et al. 2011) and those of some pathogenic bacteria 
(Daines et al. 2007; Ramage et al. 2009).  
Moreover, to obtain some insights into in vivo molecular function of TTC0125, 
an in vitro-translation inhibition assay was conducted, using a PUREFrex kit. As 
prediceted, there was no band observed for negative control (fig. 3-3-4 lane NC) 
without addition of tempalate mRNA. On the contrast, a positive control experiment 
with template tetR mRNA addition of but without TTC0125 addition produced a band 
of ca. 50.8 kDa corresponding to the molecular weight of TT_P0042 protein with a 
6×His-tag (Fig. 3-3-4 lane PC). When the mRNA was incubated with TTC0125 prior to 
translation, the band was not observed (Fig. 3-3-4 lane 1). Also, the band was not 
observed when TTC0126 was added after incubation of the mRNA with TTC0125 (Fig. 
3-3-4 lane 2). However, TT_P0042 protein was successfully translated when the mRNA 
was incubated with the TTC0125-TTC0126 complex (Fig. 3-3-4 lane 3). It seems likely 
that TTC0125 inhibits translation by degrading mRNA. 
On the other hand, pre-treatment of ribosome with TTC0125 resulted in 
decrease of the translated product (Fig. 3-3-4 lane 5), however, this decrease did not 
occur when TTC0126 was added to the ribosome-TTC0125 mixture before translation 
reaction (Fig. 3-3-4 lane 6). This observation can be explained that the active TTC0125 
degrades mRNA during translation reaction, but not affect the ribosome function. Again, 
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pre-incubation of ribosome with TTC0125-TTC0126 did not affect translation 
efficiency. 
In this chapter, I conclude that TTC0125 is a ribonuclease targeting free RNAs. 
It has no site-specific acitivity, and it inhibits translation by degrading mRNA. 
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CHAPTER IV – IDENTIFICATION OF CATALYTICALLY-IMPORTANT 
RESIDUES OF TTC0125 
Section I - Introduction 
VapC toxin contains a PIN domain of 130 amino acids in length and is predicted to 
have a ribonuclease activity. The Pfam database (Finn et al., 2010) identified 3457 
proteins belonging to the PIN-domain family (PF01850) from 490 different species 
including eukaryotes, eubacteria and archaea. Several structural analyses of PIN 
proteins indicated the active sites containing three strictly conversed amino acids 
consisting of two Asp and one Glu. And Prat VapCs contains other two less conversed 
amino acids of Asp placed in their C terminal region (Arcus et al. 2004b; Arcus et al. 
2011; Bunker et al. 2008; Das et al. 2014; Dienemann et al. 2011; Lee et al. 2015; Min 
et al. 2012). In recent years several structural analyses and experimental results 
demonstrated that the three conversed amino acid residues are important for their 
activity of PIN domain proteins (Hamilton, Manzella, Schmidt, DiMarco, & Butler, 
2014; Sharp et al., 2012b; K. S. Winther & Gerdes, 2011a), but other amino acid 
residues that may have important roles for the activity are not be paid attention 
sufficiently. Moreover, these studies only showed their role for toxin activity by 
expressing mutants of these amino acids in vivo, however, their role for enzyme activity 
has not been demonstrated until now. So I constructed several mutants in which the 
conserved amino acid residues in TTC0125 and other VapCs were replaced, and 
analyzed their effects on enzyme activity in this chapter.   
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Section II - Materials and methods 
4-2-1 Bacterial strains, plasmids and media 
 T. thermophilus HB27 was used for genome isolation and purification of total 
RNA. E. coli strains DH5αZ1 (DH5α harboring attB:: PlacI
q
-lacI, PN25-tetR, Sp
r
; Lutz 
and Bujard 1997) and Rosetta (DE3) were used for plasmid construction and expression 
of mutated TTC0125 from pZE21MCS2 (ColE1ori, PLtetO-1, Kn
r
; Lutz and Bujard 1997), 
and production of mutant proteins with pET28a, respectively. T. thermophilus and E. 
coli strains were cultured in TM medium (Koyama et al. 1986) with shaking at 70 °C 
and LB medium at 37 °C, respectively.  
4-2-2 Site-directed mutagenesis 
 Single amino acid-substitution mutants of TTC0125 were constructed using 
pZE21MCS2 plasmid harboring TTC0125 and pET28-TTC0125-TTC0126 as templates, 
primers listed in Table 4-2-1, and a QuickChange site-directed mutagenesis kit (Agilent 
Technologies). The resultant pZE21MCS2 plasmids harboring the mutant TTC0125 
were used for the growth inhibition assay, and pET28-TTC0125-TTC0126 harboring 
mutant genes were for protein purification and biochemical assays. 
4-2-3 Growth inhibition assay 
Strain DH5αZ1 harboring pZE21MCS2 plasmid containing the mutant genes 
was cultured in liquid LB medium with 50 μg/ml of kanamycin at 43 ºC. When O.D.600 
of the culture reached around 0.2, 100 ng/ml doxycycline (Dox) was added to induce 
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gene expression. Cell growth was monitored periodically by measuring O.D.600. Three 
independent experiments were performed. 
4-2-4 RNA degradation assay 
 One-hundred pmol of the wild type or mutated TTC0125 protein, dialyzed 
against Reaction buffer (50 mM Tris-HCl, 100 mM NaCl, 10 mM MgCl2, 1 mM DTT, 
pH 7.4) prior to the reaction, was incubated with one μg of total RNA from E. coli and T. 
thermophilus, prepared using a RNeasy Mini Kit (Qiagen) at 50 ºC in Reaction buffer. 
After 60 min. incubation, the reaction was stopped by adding 1x loading buffer (47.5 % 
formamide, 0.01 % SDS, 0.01 % bromophenol blue, 0.5 mg/ml EtBr, 0.5 mM EDTA) 
and placed on ice immediately. Then the samples were loaded onto a denaturing agarose 
gel (1% agarose, 6.5% formaldehyde, 0.4 M MOPS, 100 mM sodium acetate, 10 mM 
EDTA) and analyzed.  
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Table 4-2-1 Primers used in this chapter. 
Primer Sequence (5’-3’)a  
 
D4AF      GCCATATGGTGCTGGCCGCTTCCGC 
D4AR     GCGGAAGCGGCCAGCACCATATGGC 
E23AF    GAGGAGCTTTTGGCGGAACTCCGGCG 
E23AR          CGCCGGAGTTCCGCCAAAAGCTCCTC 
E40AF    CCACCCTGGCCGCAGCGGGGATCGTC 
E40AR    GACGATCCCCGCTGCGGCCAGGGTGG 
F71AF    CCGAGATCGTGCCCGCTACCGAAAGGCATG 
F71AR    CATGCCTTTCGGTAGCGGGCACGATCTCGG 
T72AF    GATCGTGCCCTTTGCCGAAAGGCATG 
T72AR    CATGCCTTTCGGCAAAGGGCACGATC 
A76DF    CCGAAAGGCATGACCGGGAGGCCATC 
A76DR    GATGGCCTCCCGGTCATGCCTTTCGG 
G94DF    GGCACCCCGCCGATCTCAACTTCGGG 
G94DR    CCCGAAGTTGAGATCGGCGGGGTGCC 
G98DF    GGGCTCAACTTCGACGACTGCCTGAGC 
G98DR     GCTCAGGCAGTCGTCGAAGTTGAGCCC 
D99AF    CTCAACTTCGGGGCCTGCCTGAGCTAC 
D99AR    GTAGCTCAGGCAGGCCCCGAAGTTGAG 
S102DF          GGGACTGCCTGGATTACGCCCTGGCC 
S102DR          GGCCAGGGCGTAATCCAGGCAGTCCC 
L105DF          CTGAGCTACGCCGACGCCCGGGTGGAG 
L105DR          CTCCACCCGGGCGTCGGCGTAGCTCAG 
V108DF          CCCTGGCCCGGGACGAGGGGGAACC 
V108DR          GGTTCCCCCTCGTCCCGGGCCAGGG 
D119AF          CTACAAGGGCCAGGCCTTTGACCGGACG 
D119AR          CGTCCGGTCAAAGGCCTGGCCCTTGTAG 
D124AF          CTTTGACCGGACGGCCCTGGCGTGGAAG 
D124AR          CTTCCACGCCAGGGCCGTCCGGTCAAAG 
a
 The mutations are underlined and shown in italics.  
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Section III – Result 
4-3-1 Conserved amino acid residues of VapCs 
An amino acid sequence alignment of TTC0125 with some “reviewed” VapCs 
in the Uniprot database was generated by the T-Coffee program (Notredame et al. 2000). 
Conserved residues are shaded, of which those conserved among all the sequences are 
in black. As shown in Fig. 4-3-1, the putative active sites in all PIN domain proteins, D4, 
E40 and D99, are also conserved in TTC0125, indicated that TTC0125 have a PIN 
domain. And some amino residues like D119 and D124 are reported to be active sites in 
some VapCs, though they are not tightly conserved. 
To find the important amino residues for enzyme activity, I chose the Asp 
(D119 and D124) exist near the C terminator in the alignment, and part of slightly 
conserved amino residues as well as tightly conserved catalytic ones. I conducted 
site-directed mutagenesis to introduce single amino acid substitutions of these residues 
to Ala or Asp, constructed mutants named D4A, E23A, E40A, F71A, T72A, A76D, 
G94D, G98D, D99A, S102D, L105D, V108D, D119A and D124A. All the Amino acid 
substitutions introduced in TTC0125 in this study are indicated above the alignment by 
arrows (Fig. 4-3-1). The mutant genes were introduced into E. coli DH5αZ1 on 
pZE21MCS2.  
4-3-2 Growth inhibition assay of TTC0125 mutants.  
E. coli DH5αZ1 harboring the resultant pZE21MCS2 plasmids containing the 
mutant TTC0125 were used for the growth inhibition assay. As shown in Fig. 4-3-2, the 
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E23A, T72A, L105D, and V108D mutants showed similar growth inhibition as the wild 
type TTC0125 gene, suggesting that these residues are not required for its toxin activity. 
The F71A mutant showed a weaker growth inhibition, suggesting that this residue may 
be required for this activity to some extent. In contrast, the D4A, E40A, A76D, G94D, 
G98D, D99A, S102D, D119A, and D124A mutants, including the mutants of the 
putative catalytic residues, had almost no effect on cell growth, demonstrating the 
importance of these residues for its in vivo toxin activity. 
4-3-3 Three-dimensional model of TTC0125 
As the three-dimensional structure of TTC0125 is currently not available, I 
have developed a three-dimensional model, using the Phyre2 program (Kelly et al. 
2015), to obtain some insight into structure-activity relationship of TTC0125. The 
Phyre2 program indicated that TTC0125 showed 37% identity with VapC30 of M. 
tuberculosis H37Rv (PDB No. 4xgr), and a model structure of the second to 128th 
amino acid of TTC0125 was constructed (Fig. 4-3-3) based on that of VapC30 with a 
100% confidence, indicating the accuracy of the model at some extent.  
Mapping of the mutated residues on the model structure (Fig. 4-3-3) indicated 
that the three highly conserved putative catalytic residues (D4, E40, D99) are located at 
one place with nearly the same topologies and distances of the side chains with those of 
VapC30. D119 placed in the same putative catalytic center region. F71, A76D, G94D, 
G98D and S102D residues, whose mutations also caused complete or partial loss of the 
activity, are located around the putative catalytic center. In the case of G98, it is located 
adjacent to one of the catalytic residue D99. On the contrary, the E23, T72, L105 and 
49 
 
V108, whose mutants showed similar growth inhibition as the wild type TTC0125 were 
located at the other side of the protein.  
4-3-4 Purification of mutants. 
To examine the mutant proteins which lost the growth inhibition activity 
biochemically, the proteins were purified by the same method as the wild type TTC0125. 
As shown in Fig. 4-3-4, all the mutant proteins could be purified as single bands. And as 
they are isolated from the TTC0125-TTC126 protein complex, it showed that all the 
mutant proteins kept their protein binding abilities.  
4-3-5 RNase assay of mutants. 
Wild type or mutated TTC0125 protein, dialyzed against Reaction buffer prior 
to the reaction, was incubated with total RNA from E. coli at 50 ºC in Reaction buffer 
for 60 min. The Fig. 4-3-5 showed the result of this RNA-degradation assay. Different 
from the wild type TTC0125 which showed an RNase activity toward both 16S and 23S 
rRNA of E. coli, the D4A, E40A, A76D, G94D, G98D, D99A, S102D, D119A and 
D124A mutants completely lost the activity, as well as the result of growth inhibition 
assays.  
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Figure 4-3-1 Amino acid sequence alignment of TTC0125 and the “reviewed” 
VapCs in the Uniprot database.  
The alignment was generated by the T-Coffee program. Conserved residues are shaded, 
of which those conserved among all of the sequences are in black. Amino acid 
substitutions introduced in TTC0125 are indicated above the alignment. 
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Figure 4-3-2 Growth inhibition assay of TTC0125 mutants. 
E. coli DH5αZ1 harboring pZE21MCS2 (a), or the plasmid containing the wild type 
TTC0125 (b), D4A (c), E23A (d), E40A (e), F71A (f), T72A (g), A76D (h), G94D (i), 
G98D (j), D99A (k), S102D (l), L105D (m), V108D (n), D119A (o), or D124A (p) were 
cultured in LB medium containing kanamycin at 43 ºC, and cell growth was monitored 
by measuring O.D.600. At O.D.600 ≈ 0.2, Dox was added to induce gene expression. 
Open circles with dotted lines indicate the culture without induction, and filled circles 
with solid lines indicate the culture with induction. Culturing was conducted three times, 
and the mean values±standard deviations are shown. 
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Figure 4-3-3 Three-dimensional model of TTC0125 constructed by the Phyre2 
program.  
Residues to which the mutations were introduced are shown with side chains and 
introduced mutations are indicated. Residues whose mutations affected growth 
inhibition activity are shown in orange and magenta, of which orange residues indicate 
the putative catalytic residues. Those whose mutations did not affect the activity are 
shown in blue. 
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Figure 4-3-4 Purification of the purified TTC0125 mutants.  
Lane 1, wild type; 2, D4A; 3, E40A; 4, A76D; 5, G94D; 6, G98D; 7, D99A; 8, S102D; 
9, D119A; 10, D124A mutants. Lanes M and C indicate molecular marker (in kDa) and 
a control experiment without incubation with TTC0125, respectively. 
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Figure 4-3-5 RNA-degrading assay of the purified TTC0125 mutants. 
Lane 1, wild type TTC0125; 2, D4A; 3, E40A; 4, A76D; 5, G94D; 6, G98D; 7, D99A; 8, 
S102D; 9, D119A; 10, D124A mutants. Lanes M and C indicate molecular markers (in 
kDa) and a control experiment without TTC0125 incubation, respectively. 
RNA-degradation assays were conducted with E. coli total RNA, and the positions of 
23S and 16S rRNA are indicated by arrows.     
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Section IV – Discussion 
In this chapter, I conducted site-directed mutagenesis to identify catalytically- 
important residues of TTC0125.  
An amino acid sequence alignment of TTC0125 with some “reviewed” VapCs 
in the Uniprot database (Fig. 4-3-1), indicates that some residues, including the putative 
catalytic residues in PIN proteins, D4, E40 and D99 in TTC0125 numbering, are 
conserved in all the VapCs. Also, some other residues are conserved in several, but not 
all, VapCs. I have selected such residues, including the catalytic residues, and 
introduced single amino acid substitutions to Ala or Asp.  
Firstly, the mutant genes were used for the growth inhibition assay. As shown 
in Fig. 4-3-2 , the E23A, T72A, L105D, and V108D mutants showed similar growth 
inhibition as the wild type TTC0125 gene, suggesting that these residues are not 
required for its toxin activity. The F71A mutant showed a weaker growth inhibition, 
suggesting that this residue may be required for this activity to some extent. In contrast, 
the D4A, E40A, A76D, G94D, G98D, D99A, S102D, D119A, and D124A 364 mutants, 
including the mutants of the putative catalytic residues, had almost no effect on cell 
growth, demonstrating the importance of these residues for its in vivo toxin activity.  
Since the three-dimensional structure of TTC0125 is currently unavailable, we 
developed a three-dimensional model using the Phyre2 program to gain insight into the  
structure-activity relationship of TTC0125 (Kelly et al. 2015). Mapping of the mutated 
residues on the model structure (Fig. 4-3-3) indicated that the 374 three putative 
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catalytic residues, whose mutations led to complete loss of growth 375 inhibition 
activity, are located in one place with nearly the same topologies and distances of the 
side chains with those of VapC30, possibly forming the catalytic center. The other 
residues whose mutations also resulted in complete or partial loss of activity, except for 
G94 and D124, are located around the putative catalytic center, suggesting 379 that 
these residues are involved in substrate binding or structural maintenance of the 380 
putative catalytic center. In the case of G98, since the Gly residue acts as a helix breaker 
and this residue is located adjacent to one of the catalytic residues, D99, G98 may be 
required for correct positioning of D99; it remains unknown as to why the mutations of 
G94D and D124A lost growth inhibition activity. The E23, T72, L105, and V108 
residues are located at the other side of the protein. Therefore, it is possible that 
mutations of these residues did not affect activity.  
In order to examine the mutant proteins which lost growth inhibition activity 
biochemically, the proteins were purified using the same method as the wild type 
TTC0125. As shown in Fig. 4-3-4, all of the mutant proteins were purified as single 
bands. Since this purification method relies on the complex formation with TTC0126, 
this result indicates that the mutations introduced did not affect binding to TTC0126. As 
expected, all mutants lost RNase activities against total RNA (Fig. 4-3-5), and one of 
the mutants, D99A, as shown in chapter III, also lost activity against mRNA (Fig. 3-3-2 
c) and translation- inhibition activity (Fig. 3-3-4). 
Finally, I conclude that Amino acid substitutions of 14 putative catalytic and 
highly conserved residues in the VapC family toxins to Ala or Asp indicated that nine 
residues are important for its protein activity. They are D4, E40, A76, G94, G98, D99, 
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S102, D119 and D124. Among them, the three tightly conserved ones, D4, E40, and 
D99, are confirmed to be catalytic residues, as the ones reported in other VapC; A76, 
G94, G98, S102, D119 and D124. are confirmed to be catalytic residues experimentally 
by this study at first.   
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CONCLUSION 
4 VapBC and 3 HicBA toxin-antitoxin loci were predicted in the genome of T. 
thermophilus HB27. BLAST analysis and phylogenetic tree based on amino acid 
sequences of the 7 toxins with typical VapC and HicA toxins confirming that TTC0113, 
TTC0125, TTC1207, and TTC1804 are VapCs, and TTC1395, TTC1549, TTC1705 are 
HicAs. 
In chapter II, I analyzed toxic function of the 7 TA loci. Toxin genes were 
expressed with or without their cognate antitoxin genes in E. coli. Fig. 2-3-2 showed 
that expression of one VapC (TTC0125) and two HicA (TTC1395, TTC1549) genes 
strictly inhibited cell growth, and the growth-inhibitory effects of the former three toxin 
genes were more evident at 43 °C than at 37 °C, indicated that these three loci function 
as classic TA systems in T. thermophilus. However, I cannot exclude the possibility that 
these four toxins may also possess toxin activities at higher temperatures, i.e. the growth 
temperature of T. thermophilus.  
 In chapter III, I focused on the TTC0125-TTC0126 locus, the only functional 
VapBC TA locus in T. thermophilus. In this chapter, I described biochemical analyses to 
identify the enzyme activity of TTC0125 and its target intracellular molecules. Firstly, 
purification of TTC0125 and TTC0126 was conducted for biochemical analyses. Using 
the method described by Winther and Gerdes (2011), toxic TTC0125 protein could be 
produced in E. coli as a TTC0125-TTC0126 protein complex and purified to 
homogeniety. Secondly, I identified the enzyme activity of TTC0125 using the 
purificated proteins of TTC0125 and TTC0126. An RNase assay was performed using 
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total RNA isolated from both E. coli and T. thermophilus as substrates (Fig. 3-3-2), 
demonstrated that TTC0125 could degrade 16S and 23S rRNA and TTC0126, the 
antitoxin of TTC0125, could completely neutralize TTC0125’s activity. To examine 
whether TTC0125 has substrate specificities or not, I checked its activity toward intact 
ribosomes (Fig. 3-3-3) and confirmed that TTC0125 only cleaves free RNA, but not 
RNA within intact ribosome. For assessment of initiator tRNA cleavage, the initiator 
tRNA of E. coli was detected by Northern blot hybridization, and showed that TTC0125 
did not react with the initiator tRNA. On the other hand, TTC0125 degrades in 
vitro-transcribed mRNA of E. coli gene (tetR) in the same manner as total RNA (Fig. 
3-3-2). Thus I concluded that TTC0125 does not have any substrate and sequence 
specificity, rather it degrades free RNA. Moreover, to obtain some insights into in vivo 
molecular function of TTC0125, an in vitro-translation inhibition assay was conducted, 
using a PUREFrex kit. The result shown in Fig. 3-3-4 indicated that TTC0125 TTC0125 
inhibits translation by degrading mRNA, but not ribosome. 
In chapter IV, I conducted site-directed mutagenesis to identify catalytically- 
important residues of TTC0125. An amino acid sequence alignment of TTC0125 with 
some “reviewed” VapCs in the Uniprot database (Fig. 4-3-1), indicates that some 
residues, including the putative catalytic residues in PIN proteins, D4, E40 and D99 in 
TTC0125 numbering, are conserved in all the VapCs. Also, some other residues are 
conserved in several, but not all, VapCs. I have selected such residues, including the 
catalytic residues, and introduced single amino acid substitutions to Ala or Asp. Growth 
inhibition assay of 14 mutants of TTC0125 indicated that E23A, T72A, L105D, and 
V108D did not lose their toxic activity when expressed them in E.coli, suggesting that 
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these residues are not required for its activity. The F71A mutant showed a weaker 
growth inhibition, suggesting that this residue may be required for this activity to some 
extent. In contrast, the D4A, E40A, A76D, G94D, G98D, D99A, S102D, D119A, and 
D124A 364 mutants, including the mutants of the putative catalytic residues, had almost 
no effect on cell growth, demonstrating the importance of these residues for its toxin 
activity. By RNase assay of purified mutant proteins, I confirmed that nine residues 
conserved in TTC0125 are important for the activity of enzyme.They are D4, E40, A76, 
G94, G98, D99, S102, D119 and D124. Among them, the three tightly conserved ones, 
D4, E40, and D99, are confirmed to be catalytic residues, as reported in other VapC; and 
A76, G94, G98, S102, D119 and D124 are confirmed to be catalytic residues 
experimentally by this study at first.   
In conclusion, I characterized seven putative TA loci in T. thermophilus, and 
found that the three loci, TTC0125-TTC0126, TTC1395-TTC1396, and TTC1705-397 
TTC1706, function as a TA module, indicated by the E. coli growth-inhibition assay. 
Biochemical analysis indicated that TTC0125 catalyzes degradation of RNA and 
inhibits translation by degrading free mRNA, and TTC0126 inhibits its activity as the 
antitoxin. Nine catalytically-important residues in TTC0125, including the three 
putative catalytic residues, were identified, most of which are located near the catalytic 
center of the three-dimensional model. Most vapBC loci in microorganisms consist of a 
bicystronic operon but the TTC0125-TTC0126 locus is included in a gene cluster 
encoding metabolic enzymes related to the glyoxylate cycle. It is possible that the 
physiological function of TTC0125-TTC0126 is related to this cycle.  
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